相关实验视频

Updated: Jul 25, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

干扰素信号传递促进了对染色体不稳定的耐受性,在癌的转移性演变过程中促进了染色体不稳定性

Luigi Perelli¹, Federica Carbone^2,3, Li Zhang²

¹Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. LPerelli@mdanderson.org.

|June 26, 2023

概括

了解癌症转移是关键的. 这项研究揭示了基因变化,如9p21中断和干扰素路径变化,如何驱动癌的传播,以及干扰素信号如何限制瘤的侵略性发展.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
癌症生物学癌症生物学

背景情况:

转移性扩散是侵袭性癌症的一个关键决定因素.
了解转移性进展的分子驱动因素对于开发有效疗法至关重要.

研究的目的:

为了研究导致转移性瘤的遗传变化.
阐明干扰素信号传导在抑制癌症进化过程中体克隆传播中的作用.

主要方法:

在体内CRISPR-Cas9基因组编辑生成体质马赛克基因工程模型.
对副本数量变化的跨物种分析.
在体外和体外基因组工程与功能丧失研究.
开发一种用于染色体21q部分三症的模型.

主要成果:

9p21位点的破坏通过快速获得复杂的型驱动系统性疾病.
经常出现的拷贝数变化,包括21q损失和干扰素途径失调,是转移潜力的主要驱动因素.
干扰素受体基因集群在转移性进展期间管理染色体不稳定性方面表现出剂量依赖的效果.

结论:

干扰素信号传递在抑制形克隆在癌症演变中的传播方面发挥着至关重要的作用.
这项工作提供了关于细胞癌进展的驱动因素的关键知识.
确定了关键的分子路径和遗传改变,有助于癌转移性传播.

更多相关视频

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Intracellular Signaling Affects Focal Adhesions

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...